H Reis1, F Mairinger2, S Ting2, N Nagy3, K E Witzke4, M Kohl4, B Sitek4, C Niedworok5, B Hadaschik5, P Nyirády3, T Szarvas3,5. 1. Institut für Pathologie, Westdeutsches Tumorzentrum, Universitätsmedizin Essen, Universität Duisburg-Essen, Essen, Deutschland. henning.reis@uk-essen.de. 2. Institut für Pathologie, Westdeutsches Tumorzentrum, Universitätsmedizin Essen, Universität Duisburg-Essen, Essen, Deutschland. 3. Klinik für Urologie, Semmelweis Universität, Budapest, Ungarn. 4. Medizinisches Proteom Center, Ruhr-Universität Bochum, Bochum, Deutschland. 5. Klinik für Urologie, Westdeutsches Tumorzentrum, Universitätsmedizin Essen, Universität Duisburg-Essen, Essen, Deutschland.
Abstract
BACKGROUND: Urachal cancer is a rare type of cancer, often following a clinically aggressive course. Due to its rarity, knowledge about its molecular background is still limited. In addition, no sufficiently reliable diagnostic markers are available. OBJECTIVES: The aim of the present study is to give an overview of our recent molecular projects on urachal cancer and to connect it with current literature in the field. MATERIALS AND METHODS: Three projects are introduced. The first project identified and validated diagnostic biomarkers in urachal adenocarcinomas compared to colorectal adenocarcinomas and primary adenocarcinomas of the bladder using various proteomic methods. In the second project, the most relevant differential diagnostic markers between urachal adenocarcinomas and colorectal adenocarcinomas compared to normal tissue (urachal remnants) were determined by analyzing a miRNA panel. Sequence analyses were performed in the third project. The focus was on molecular differences to colorectal adenocarcinomas and urothelial carcinomas. RESULTS AND CONCLUSIONS: We detected potential biomarker candidates for the immunohistochemical differential-diagnosis and generated a miRNA-based diagnostic scoring system with a potentially high differential-diagnostic significance. The sequence analyses data confirm the molecular autonomy of the urachal adenocarcinomas compared to other entities.
BACKGROUND:Urachal cancer is a rare type of cancer, often following a clinically aggressive course. Due to its rarity, knowledge about its molecular background is still limited. In addition, no sufficiently reliable diagnostic markers are available. OBJECTIVES: The aim of the present study is to give an overview of our recent molecular projects on urachal cancer and to connect it with current literature in the field. MATERIALS AND METHODS: Three projects are introduced. The first project identified and validated diagnostic biomarkers in urachal adenocarcinomas compared to colorectal adenocarcinomas and primary adenocarcinomas of the bladder using various proteomic methods. In the second project, the most relevant differential diagnostic markers between urachal adenocarcinomas and colorectal adenocarcinomas compared to normal tissue (urachal remnants) were determined by analyzing a miRNA panel. Sequence analyses were performed in the third project. The focus was on molecular differences to colorectal adenocarcinomas and urothelial carcinomas. RESULTS AND CONCLUSIONS: We detected potential biomarker candidates for the immunohistochemical differential-diagnosis and generated a miRNA-based diagnostic scoring system with a potentially high differential-diagnostic significance. The sequence analyses data confirm the molecular autonomy of the urachal adenocarcinomas compared to other entities.
Authors: Mahul B Amin; Steven C Smith; John N Eble; Priya Rao; William W L Choi; Pheroze Tamboli; Robert H Young Journal: Am J Surg Pathol Date: 2014-08 Impact factor: 6.394
Authors: Ana Collazo-Lorduy; Mireia Castillo-Martin; Li Wang; Vaibhav Patel; Gopa Iyer; Emmet Jordan; Hikmat Al-Ahmadie; Issa Leonard; William K Oh; Jun Zhu; Russell B McBride; Carlos Cordon-Cardo; David B Solit; John P Sfakianos; Matthew D Galsky Journal: Eur Urol Date: 2016-05-10 Impact factor: 20.096
Authors: H Max Bruins; Otto Visser; Martine Ploeg; Christina A Hulsbergen-van de Kaa; Lambertus A L M Kiemeney; J Alfred Witjes Journal: J Urol Date: 2012-08-15 Impact factor: 7.450
Authors: Anuradha Gopalan; David S Sharp; Samson W Fine; Satish K Tickoo; Harry W Herr; Victor E Reuter; Semra Olgac Journal: Am J Surg Pathol Date: 2009-05 Impact factor: 6.394
Authors: In Kyong Kim; Joo Yong Lee; Jong Kyou Kwon; Jae Joon Park; Kang Su Cho; Won Sik Ham; Sung Joon Hong; Seung Choul Yang; Young Deuk Choi Journal: Korean J Urol Date: 2014-09-05